Molecular biology of apoptotic, necrotic, and necroptotic cell death

No abstract is available for this paper.

• Publication year

  2022

• Venue

  Pharmacokinetics and Toxicokinetic Considerations

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1016/b978-0-323-98367-9.00027-5
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacogenomics and drug metabolism

  2021cited by this paper
• Pharmacokinetics and biopharmaceutics: “a leader or attendant”

  2021cited by this paper
• Kinetics of maternal–fetal drug transfer

  2021cited by this paper
• Pharmacokinetics aspects of structural modifications in drug design and therapy

  2021cited by this paper
• Biosimilars accessible in the market for the treatment of cancer.

  2021cited by this paper
• Drug metabolic kinetics

  2021cited by this paper
• Bioanalytical method development and validation for establishing bioavailability and bioequivalence

  2021cited by this paper
• Biopharmaceutical considerations in the pediatric and geriatric formulation development

  2021cited by this paper
• “Organ-on-a-chip”-based physiologically relevant pharmacokinetic models

  2021cited by this paper
• Pharmacokinetics aspects of biotechnological products

  2021cited by this paper
• Software used in ADME computation

  2021cited by this paper
• Molecular mechanisms of circadian rhythm and its influence on the pharmacokinetics of drugs

  2021cited by this paper
• Implications for sex-related issues in clinical pharmacology and biopharmaceutics

  2021cited by this paper
• Influence of fever on pharmacokinetics of drugs

  2021cited by this paper
• Revamping the pharmacokinetics of poorly soluble drugs using different formulations

  2021cited by this paper
• Overview of biopharmaceutics and pharmacokinetics

  2021cited by this paper
• Pharmacokinetics modeling in drug delivery

  2021cited by this paper
• Resealed erythrocytes (RBCs) and their biomedical application

  2020cited by this paper
• Recombinant blood products and therapeutic enzymes: An update

  2020cited by this paper
• Hydrotropy, mixed hydrotropy, and mixed solvency as trending concept for solubilization of lipophilic drugs

  2020cited by this paper
• Endosomal escape tendency of drug delivery systems to mediate cytosolic delivery of therapeutics

  2020cited by this paper
• Dendrimers as novel drug-delivery system and its applications

  2020cited by this paper
• Self-microemulsifying drug-delivery system: ongoing challenges and future ahead

  2020cited by this paper
• Cancer-targeted chemotherapy: Emerging role of the folate anchored dendrimer as drug delivery nanocarrier

  2020cited by this paper
• Targeting necroptosis in anticancer therapy: mechanisms and modulators

  2020cited by this paper
• Nanomedicines accessible in the market for clinical interventions.

  2020cited by this paper
• Development of Metronidazole Loaded Chitosan Nanoparticles Using QbD Approach—A Novel and Potential Antibacterial Formulation

  2020cited by this paper
• Recent advances in regenerative medicine

  2020cited by this paper
• New advances in insulin products

  2020cited by this paper
• Recent advancements in solubilization of hydrophobic drugs

  2020cited by this paper
• 3D printing as an emerging tool in pharmaceutical product development

  2020cited by this paper
• Gold nanoparticles: An advanced drug delivery and diagnostic tool

  2020cited by this paper
• Gene delivery to tackle diabetic nephropathy

  2020cited by this paper
• The molecular machinery of regulated cell death

  2019cited by this paper
• RIP1/RIP3-regulated necroptosis as a target for multifaceted disease therapy (Review)

  2019cited by this paper
• Caspases in Cell Death, Inflammation, and Disease.

  2019cited by this paper
• Microemulsion as drug and gene delivery vehicle: an inside story

  2019cited by this paper
• The TNF Family of Ligands and Receptors: Communication Modules in the Immune System and Beyond.

  2019cited by this paper
• Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins

  2019cited by this paper
• Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018

  2018cited by this paper
• Carbon nanotubes (CNTs) based advanced dermal therapeutics: current trends and future potential.

  2018cited by this paper
• Repurposing anticancer drugs for targeting necroptosis

  2018cited by this paper
• Bypassing drug resistance by triggering necroptosis: recent advances in mechanisms and its therapeutic exploitation in leukemia

  2018cited by this paper
• Carbon nanotube scaffolds as emerging nanoplatform for myocardial tissue regeneration: A review of recent developments and therapeutic implications.

  2018cited by this paper
• Necroptosis: a regulated inflammatory mode of cell death

  2018cited by this paper
• Caspase‐8: regulating life and death

  2017cited by this paper
• Carbon Nanotubes in Targeting and Delivery of Drugs

  2017cited by this paper
• Recent advances in hyaluronic acid-decorated nanocarriers for targeted cancer therapy.

  2017cited by this paper
• Homoharringtonine, a clinically approved anti-leukemia drug, sensitizes tumor cells for TRAIL-induced necroptosis

  2015cited by this paper
• Broad targeting of resistance to apoptosis in cancer

  2015cited by this paper
• Apoptosis, autophagy, necroptosis, and cancer metastasis

  2015cited by this paper
• Hollow Gold Nanoparticals as Biocompatible Radiosensitizer: An In Vitro Proof of Concept Study

  2015cited by this paper
• Necroptosis: Molecular Signalling and Translational Implications

  2014cited by this paper
• FLIP: Molecular switch between apoptosis and necroptosis

  2014cited by this paper
• A potent Chk1 inhibitor is selectively cytotoxic in melanomas with high levels of replicative stress

  2013cited by this paper
• Caspase-9, caspase-3 and caspase-7 have distinct roles during intrinsic apoptosis

  2013cited by this paper
• The mechanism of necroptosis in normal and cancer cells

  2013cited by this paper
• Inhibitor of apoptosis (IAP) proteins-modulators of cell death and inflammation.

  2013cited by this paper
• Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy

  2013cited by this paper
• Many stimuli pull the necrotic trigger, an overview

  2011cited by this paper
• Caspase-3 deficiency reveals a physiologic role for Smac/DIABLO in regulating programmed cell death

  2011cited by this paper
• Calcium and cell death mechanisms: a perspective from the cell death community.

  2011cited by this paper
• Molecular mechanisms of necroptosis: an ordered cellular explosion

  2010cited by this paper
• Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha.

  2009cited by this paper
• RIP kinases at the crossroads of cell death and survival.

  2009cited by this paper
• Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation.

  2009cited by this paper
• RIP3, an Energy Metabolism Regulator That Switches TNF-Induced Cell Death from Apoptosis to Necrosis

  2009cited by this paper
• Secondary necrosis in multicellular animals: an outcome of apoptosis with pathogenic implications

  2008cited by this paper
• Caspases in apoptosis and beyond

  2008cited by this paper
• Molecular mechanisms and pathophysiology of necrotic cell death.

  2008cited by this paper
• TNFα and reactive oxygen species in necrotic cell death

  2008cited by this paper
• BCL-2 Family Proteins: Critical Checkpoints of Apoptotic Cell Death

  2007cited by this paper
• The inhibitors of apoptosis (IAPs) as cancer targets

  2007cited by this paper
• Apoptosis: A Review of Programmed Cell Death

  2007cited by this paper
• TNF-induced activation of the Nox1 NADPH oxidase and its role in the induction of necrotic cell death.

  2007cited by this paper
• Mechanisms of cytochrome c release from mitochondria

  2006cited by this paper
• Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy

  2006cited by this paper
• Role of Bax and Bak in mitochondrial morphogenesis

  2006cited by this paper
• Combined ectopic expression of Pdx1 and Ptf1a/p48 results in the stable conversion of posterior endoderm into endocrine and exocrine pancreatic tissue.

  2006cited by this paper
• Molecular Biology of Apoptosis in Ischemia and Reperfusion

  2005cited by this paper
• The inhibitor of apoptosis protein family and its antagonists in acute leukemias

  2004cited by this paper
• Differential contribution of necrosis and apoptosis in myocardial ischemia-reperfusion injury.

  2004cited by this paper
• Antiapoptotic BCL-2 is required for maintenance of a model leukemia.

  2004cited by this paper
• Alkylating DNA damage stimulates a regulated form of necrotic cell death.

  2004cited by this paper
• Toxic proteins released from mitochondria in cell death

  2004cited by this paper
• Analysis of the composition, assembly kinetics and activity of native Apaf‐1 apoptosomes

  2004cited by this paper
• Fas (CD95/Apo-1) ligand regulation in T cell homeostasis, cell-mediated cytotoxicity and immune pathology.

  2003cited by this paper
• A Role for Tumor Necrosis Factor Receptor-2 and Receptor-interacting Protein in Programmed Necrosis and Antiviral Responses*

  2003cited by this paper
• Characterization of cell death induced by ethacrynic acid in a human colon cancer cell line DLD‐1 and suppression by N‐acetyl‐l‐cysteine

  2003cited by this paper
• BAD and glucokinase reside in a mitochondrial complex that integrates glycolysis and apoptosis

  2003cited by this paper
• Cytotoxic T lymphocytes: all roads lead to death

  2002cited by this paper
• IAP proteins: blocking the road to death's door

  2002cited by this paper
• Bid acts on the permeability transition pore complex to induce apoptosis

  2000cited by this paper
• Direct Cleavage by the Calcium-activated Protease Calpain Can Lead to Inactivation of Caspases*

  2000cited by this paper
• Chronopharmacokinetics

  1998cited by this paper
• Regulation of reactive oxygen species-induced apoptosis and necrosis by caspase 3-like proteases

  1998cited by this paper
• The immunophilin FKBP12 functions as a common inhibitor of the TGF beta family type I receptors.

  1996cited by this paper

• Bacterial programmed cell death and toxin-antitoxin system in bacteria

  2025cites this paper